Typical and atypical Alzheimer's disease

One disease can affect different brain networks first

Alzheimer's disease is associated with amyloid plaques and tau-related changes in the brain. People can have the same broad disease biology while developing different patterns of symptoms.

The symptoms often reflect which brain networks are affected most strongly at the beginning. Memory networks are affected first in the most familiar form. Visual, language, behavioral, or executive networks may lead the presentation in an atypical form.

These categories are useful, but people do not always fit neatly into one box. Symptoms can overlap, and the pattern usually broadens as the disease progresses.

Typical, memory-led Alzheimer's disease

The most common presentation begins with episodic memory, the ability to learn and retain new experiences and information.

A person may repeat a question, forget a recent conversation, lose track of an appointment, or need increasing help remembering the steps of a familiar task. The problem is more than occasionally misplacing an item or taking longer to recall a name. New information does not stay available in the way it once did.

Other abilities, including language, navigation, judgment, and daily function, may become affected over time. Memory-led Alzheimer's disease is called "typical" because it is common, not because every person follows the same course.

Posterior cortical atrophy

In posterior cortical atrophy, or PCA, the first difficulty is often with how the brain interprets visual and spatial information. The eyes may be working, but the brain has trouble making sense of what the eyes see.

A person may have difficulty:

• reading a line of text;
• locating an object that is directly in view;
• judging distance, depth, or the position of a step;
• navigating a familiar room;
• recognizing an object or using it correctly;
• coordinating vision with reaching or dressing;
• performing calculations or writing.

People may visit an optometrist or ophthalmologist several times before the problem is recognized as neurological. Memory can be relatively preserved at the beginning, although it may change later.

Alzheimer's disease is the most common underlying cause of PCA, but PCA is a clinical syndrome rather than a pathology. Other diseases can occasionally produce a similar pattern. Biomarkers help determine whether Alzheimer's biology is present.

Logopenic variant primary progressive aphasia

In logopenic variant primary progressive aphasia, or lvPPA, language is the first and clearest area of change.

A person may know what they want to say but pause while searching for the word. They may have trouble repeating a long phrase or sentence, lose the thread of a sentence before it is complete, or make errors in the sounds within a word. Speech may become slower because of the searching, even though the muscles used for speech are working.

Early on, grammar and the meaning of individual words may be more intact than word retrieval and sentence repetition. This pattern helps distinguish lvPPA from other forms of primary progressive aphasia.

Alzheimer's disease is the most common underlying cause of lvPPA, but it is not the only possible cause. PPA describes the language syndrome. Biomarkers help identify the disease producing it.

Aphasia is a disorder of language. It is not a measure of intelligence or of how much a person understands about their own life.

Behavioral and dysexecutive Alzheimer's disease

Alzheimer's disease can rarely begin with prominent changes in behavior, judgment, planning, or problem-solving. These presentations were once grouped under the term frontal-variant Alzheimer's disease. Current clinical writing more often separates them into behavioral Alzheimer's disease and dysexecutive Alzheimer's disease.

In a behavior-led presentation, a person may become unusually apathetic, make poor social judgments, or behave in ways that seem out of character.

In a dysexecutive presentation, the main difficulty may be organizing, prioritizing, shifting between tasks, solving a multistep problem, or keeping track of the larger goal while working through details.

These patterns can resemble behavioral-variant FTD. History and examination remain important, but symptoms alone may not reliably identify the underlying disease. Alzheimer's biomarkers and the regional pattern on imaging can help separate the possibilities.

Why does the distinction matter?

When Alzheimer's disease does not begin with memory loss, diagnosis is often delayed. A visual presentation may be mistaken for an eye problem. A language presentation may be attributed to stress or hearing. A behavioral or executive presentation may be mistaken for depression, another psychiatric illness, or FTD.

Recognizing the pattern can lead to more appropriate testing and support. It can also help families understand why a person may perform well on one familiar memory task while struggling profoundly with reading, speaking, navigating, or organizing daily life.

The clinical pattern also affects practical care. Someone with PCA may need visual and environmental adaptations. Someone with lvPPA may benefit from early speech-language support and communication planning. Someone with executive difficulty may need help structuring complex tasks even when some memory abilities appear relatively strong.

How is atypical Alzheimer's disease evaluated?

The evaluation begins with the first symptom and how the pattern developed. Useful information may include:

• neurological examination;
• cognitive or neuropsychological testing tailored to the affected ability;
• language, visual, or movement assessment when indicated;
• MRI to evaluate regional patterns and other structural explanations;
• FDG PET in selected cases to examine patterns of brain metabolism;
• blood, spinal fluid, or PET biomarkers to determine whether Alzheimer's biology is present.

Imaging and biomarkers answer different questions. MRI or FDG PET may show which network is affected. An amyloid or phosphorylated-tau biomarker may show whether Alzheimer's disease is the likely biological cause. Neither replaces the history of what changed first.

The most useful description may have two parts

"Alzheimer's disease" names the likely biology. Terms such as PCA or lvPPA describe how that biology is affecting the person.

Using both levels can be more informative than forcing every presentation into a memory-first model. It tells us not only which disease may be present, but which brain functions need support now.